Vimarsana
Biggest News Aggregation in the World

Page 3 - Hematologic Malignancy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Malignancy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Malignancy Today - Breaking & Trending Today

#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma - Vimarsana News

#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma

Click to read this study in The Lancet Oncology.

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19? - Vimarsana News

What is the impact of anticancer therapy on patients with hematologic malignancies and COVID-19?

Researchers performed a systematic review and meta-analysis following the PRISMA guidelines.

FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kids - Vimarsana News

FDA Panel Backs Gene Tx for Degenerative Brain Disorder in Kids

Advisers unanimously recommend approval for pediatric ALD patients without HLA-matched donors

A Pandemic Risk Reality Check for the Immunocompromised - Vimarsana News

A Pandemic Risk Reality Check for the Immunocompromised

Studies indicate the level of risk may not warrant such a broad, catastrophizing narrative

Clinical Challenges: Allogeneic Transplant in Older AML Patients - Vimarsana News

Clinical Challenges: Allogeneic Transplant in Older AML Patients

New research looks at best candidates for this treatment